Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDD
MOVEDEP
Avaliação de Uma intervenção de promoção Atividade física em Pacientes Com depressão Maior em Atendimento Ambulatorial (MOVEDEP): um Ensaio clínico Randomizado
1 other identifier
interventional
130
1 country
1
Brief Summary
Randomized clinical trial that aims to increase physical activity levels in people with depression and to evaluate if the increase on PA levels has impact on clinical and biological measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Mar 2016
Typical duration for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 28, 2017
CompletedFirst Posted
Study publicly available on registry
January 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedFebruary 7, 2018
February 1, 2018
2.8 years
June 28, 2017
February 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depressive symptoms (blinded assessment)
Hamilton scale for depressive symptoms assessed by a blinded psychiatrist. Clinician-administered semi-structured interview with 17 questions. It is designed to measure the severity of depressive symptoms in patients with a primary depressive illness. Higher scores means higher depressive symptoms. The cutoffs are the following: following severity ranges for the HAMD: no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe depression (≥24). The maximum score is 52.
At the end of the intervention (6 months)
Secondary Outcomes (6)
Physical activity - self-report
At the end of the intervention (6 months)
Physical activity levels - objective measure
At the end of the intervention (6 months)
Quality of life
At the end of the intervention (6 months)
Depressive symptoms (self-reported)
At the end of the intervention (6 months)
Melancholia
At the end of the intervention (6 months)
- +1 more secondary outcomes
Study Arms (2)
Physical activity promotion + TAU
ACTIVE COMPARATORPhysical activity promotion based on: * Pedometers use; * Weekly contact (telephone or face-to-face); * Contact based on a self-determination theory. TAU: Treatment as usual, which include medications. Medications were prescribed by psychiatrists not involved in the study participation.
Control
PLACEBO COMPARATORWeekly calls with general health content. TAU: Treatment as usual, which include medications. Medications were prescribed by psychiatrists not involved in the study participation.
Interventions
Pedometer: Each patient will receive a pedometer with increasing weekly aims on number of steps during the trial. The number of steps to be achieved starts on 4.000 and increases progressively until the end of the trial. Behavioral strategy based on STD theory, and the assessment of barriers and facilitators of each patient. All patients were receiving treatment as usual
Eligibility Criteria
You may qualify if:
- age: 18 - 65 years;
- diagnosis of Major Depressive Disorder (DSM-IV), assessed by a trained psychiatrist;
- score 7 or more in the HAM-D;
- do not present clinical comorbidities that limit or contra-indicate the practice of physical activity;
- be starting depression treatment at the Programa de transtorno do humor (PROTHUM) ;
- have acess to a computer and have a facebook account;
- be able to read and sign the consent term.
You may not qualify if:
- present other psychiatric diagnosis such as bipolar disorder, schizophrenia or use of alcohol or other drugs;
- be not liberated to the practice of physical exercises by the assistant psychiatrist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Related Publications (3)
Schuch FB, Vasconcelos-Moreno MP, Borowsky C, Zimmermann AB, Rocha NS, Fleck MP. Exercise and severe major depression: effect on symptom severity and quality of life at discharge in an inpatient cohort. J Psychiatr Res. 2015 Feb;61:25-32. doi: 10.1016/j.jpsychires.2014.11.005. Epub 2014 Nov 21.
PMID: 25439084BACKGROUNDStubbs B, Vancampfort D, Rosenbaum S, Ward PB, Richards J, Ussher M, Schuch FB. Challenges Establishing the Efficacy of Exercise as an Antidepressant Treatment: A Systematic Review and Meta-Analysis of Control Group Responses in Exercise Randomised Controlled Trials. Sports Med. 2016 May;46(5):699-713. doi: 10.1007/s40279-015-0441-5.
PMID: 26707338BACKGROUNDSchuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. J Psychiatr Res. 2016 Jun;77:42-51. doi: 10.1016/j.jpsychires.2016.02.023. Epub 2016 Mar 4.
PMID: 26978184BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marcelo B Fleck, PhD
Researcher
Central Study Contacts
PhD
CONTACT
Felipe Schuch, PhD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2017
First Posted
January 19, 2018
Study Start
March 1, 2016
Primary Completion
December 1, 2018
Study Completion
May 1, 2019
Last Updated
February 7, 2018
Record last verified: 2018-02